Aspirin stop or continue for older heart patients
This trial checks if it is safe to stop taking daily aspirin after a heart attack and a stent procedure, compared to continuing it. It aims to help older adults avoid unnecessary bleeding while preventing another heart attack or stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older and currently take low-dose aspirin (150 mg or less) every day.
- You had a heart attack or unstable angina treated with a stent 2 to 8 years ago.
- You have not had a heart attack, stroke, or any heart procedure since that event.
- You are not taking other blood thinners or antiplatelet drugs.
- You can understand Norwegian or English and give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether older adults with stable heart disease can safely stop taking daily aspirin after two years without increasing the risk of heart attack or stroke. It may help reduce the side effects of long-term aspirin use.
This study looks at whether stopping aspirin after a month of dual antiplatelet therapy (aspirin plus clopidogrel) is safe and effective for people who had a heart attack and received stents. It compares staying on aspirin long-term versus switching to only clopidogrel to prevent future heart problems while lowering bleeding risk.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
This study compares two different daily doses of aspirin (50 mg vs 100 mg) when taken with a standard blood thinner (P2Y12 inhibitor) after getting a heart stent. It aims to see if a lower aspirin dose works just as well with fewer side effects.
This study compares a lower dose of aspirin to the standard dose for people who had a heart attack and a stent placed. The goal is to see if the lower dose works just as well with fewer side effects.
This study compares whether a lower dose of aspirin (50 mg) works as well as a standard dose (100 mg) for older adults who have had heart attacks, strokes, or other heart and blood vessel problems. The goal is to find the safest effective dose to prevent future events.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.